The place of arterial allograft in reconstructive surgery of the main arteries of the lower extremities

Kalinin R.E.

Ryazan State Medical University

Solanik N.A.

Ryazan State Medical University

Suchkov I.A.

Ryazan State Medical University;
Regional Clinical Hospital

Suchkov I.A.

Ryazan State Medical University

SPIN RSCI: 6473-8662
Scopus AuthorID: 56001271800
ResearcherID: M-1180-2016
ORCID: 0000-0002-1292-5452

Egorov A.A.

Ryazan State Clinical Hospital

Kaprov V.V.

Ryazan State Clinical Hospital

The place of arterial allograft in reconstructive surgery of the main arteries of the lower extremities

Authors:

Kalinin R.E., Solanik N.A., Suchkov I.A., Suchkov I.A., Egorov A.A., Kaprov V.V.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2020;(9): 69‑74

DOI: 10.17116/hirurgia202009169

Downloaded: 81

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Kalinin RE, Solanik NA, Suchkov IA, Suchkov IA, Egorov AA, Kaprov VV. The place of arterial allograft in reconstructive surgery of the main arteries of the lower extremities. Pirogov Russian Journal of Surgery. 2020;(9):69‑74. (In Russ.)
https://doi.org/10.17116/hirurgia202009169

Подписка 2025 (Pirogov Russian Journal of Surgery)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Endovascular treatment of deep femoral artery lesion in high-risk patients with critical lower limb ischemia. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(3):266-271

Surgical technique and early results of tricuspid valve replacement with mitral homograft. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):499-505

Critical limb ischemia, especially in the absence of autologous vein, prosthetic and native vascular infections are isolated diseases for which there currently doesn’t have best surgical treatment. Vascular allografts may be the treatment of choice for these patients. In this analysis, we tried to reflect the directions of development of vascular allotransplantation, global trends related to indications for their use, methods of conservation, degradation and endothelial dysfunction. At the present time there doesn’t have meta-analyzes on the efficiency of using arterial allografts or other options for implantation (synthetic graft, xenografts) for critical limb ischemia and graft and native infections. Now it is wrong to recommend using them always. Further studies of their performance are necessary. In addition, development of graft control techniques is also needed when rejection develops. Currently, there are no special diagnostic markers, the assessment of which could save patients with immune-mediated dilatation and dysfunction of allografts.

Keywords:

allotransplantation

allograft

homograft

critical limb ischemia

graft infection

Authors:

Kalinin R.E.

Ryazan State Medical University

Solanik N.A.

Ryazan State Medical University

Suchkov I.A.

Ryazan State Medical University;
Regional Clinical Hospital

Suchkov I.A.

Ryazan State Medical University

SPIN RSCI: 6473-8662
Scopus AuthorID: 56001271800
ResearcherID: M-1180-2016
ORCID: 0000-0002-1292-5452

Egorov A.A.

Ryazan State Clinical Hospital

Kaprov V.V.

Ryazan State Clinical Hospital

Accepted:

10.07.2020

List of references:

Suchkov IA, Pshennikov AS, Gerasimov AA, Agapov AB, Kamaev AA. Prevention of restenosis in reconstructive surgery of the main artery. Nauka molodyh (Eruditio Juvenium). 2013;2:12-19. (In Russ.).
Moreira C, Leung A, Farber A, Rybin D, Doros G, Siracuse JJ, Kalish J, Eslami MH. Alternative conduit for infrageniculate bypass in patients with critical limb ischemia. J Vasc Surg. 2016;64:131-139.
Albers M, Battistella VM, Romiti M, Rodrigues AAE, Pereira CAB. Meta-analysis of polytetrafluoroethylene bypass grafts to infrapopliteal arteries. J Vasc Surg. 2003;37:1263-1269.
DeBakey ME, Creech O Jr. Occlusive disease of the aorta and its treatment by resection and homograft replacement. Ann Surg. 1954;140:290-310.
Knox WG, Miller RE. Long-term appraisal of aortic and arterial homografts implanted in years 1954—1957. Ann Surg. 1970;172(6):1076-1078.
Kalinin RE, Suchkov IA, Pshennikov AS. Correction of endothelial dysfunction as a component in the treatment of atherosclerosis of lower limb arteries. Angiologiya i sosudistaya hirurgiya. 2014;20(3)17-22. (In Russ.).
Abrahimi P, Liu R, Pober JS. Blood Vessels in Allotransplantation. Am J Transplant. 2015;15:1748-1754.
Kalinin RE, Suchkov IA, Nikiforov AA, Pshennikov AS. The dynamics of some biochemical parameters in patients with atherosclerosis of lower limb arteries at different times after reconstructive operations. Rossijskij mediko-biologicheskij vestnik im. akad. I.P. Pavlova. 2012;20(1):42-45. (In Russ.). https://doi.org/10.17816/pavlovj2012142-45
Kalinin RE, Pshennikov AS, Suchkov IA, Abalenihina YuV, Mzhavanadze ND. Oxidative carbonylation of proteins in experimental hind-limb ischaemia-reperfusion injury. Angiologiya i sosudistaya hirurgiya. 2017;23(3):32. (In Russ.).
Boren CH, Roon AJ, Moore WS. Maintenance of viable arterial allografts by cryopreservation. Surgery. 1978;83:382-391.
Albertini J-N, Barral X, Branchereau A. Infrainguinal arterial allografts for limb salvage. In: Branchereau A, Jacobs M. Critical Limb Ischaemia. Armonk, NY: Futura Publishing Company, Inc.; 1999.
Novotny R, Slizova D, Hlubocky J, Krs O, Spatenka J, Burkert J, Fiala R, Mitas P, Mericka P, Spacek M, Hlubocka Z, Lindner J. Cryopreserved human aortic root allografts arterial wall: structural changes occurring during thawing. PLOS ONE. 2017;12(4):e0175007. https://doi.org/10.1371/journal.pone.0175007
Ku DD, Winn MJ, Grigsby T, Caulﬁeld JB. Humancoronary vascular smooth muscle and endothelium-dependent responses after storage at — 75 degrees C. Cryobiology. 1992;29(2):199-209.
Giglia JS, Ollerenshaw JD, Dawson PE, Black KS, Abbott WM. Cryopreservation prevents arterial allograft dilation. Annals of Vascular Surgery. 2002;16(6):762-767.
Prager M, Holzenbein Th, Aslim E, Domenig Ch, Muhlbacher F, Kretschmer G. Fresh arterial homograft transplantation: A novel concept for critical limb ischaemia. European Journal of Vascular and Endovascular Surgery. 2002;24(4):314-321.
Kieffer E, Gomes D, Chiche L, Fleron MH, Koskas F, Bahnini A. Allograft replacement for infrarenal aortic graft infection: early and late results in 179 patients. J Vasc Surg. 2004;39(5):1009-1017.
Harlander-Locke MP, Harmon LK, Lawrence PF, Oderich GS, McCready RA, Morasch MD, Feezor RJ. The use of cryopreserved aortoiliac allograft for aortic reconstruction in the United States. Journal of Vascular Surgery. 2014;59(3):669-674.
Müller-Schweinitzer E. Cryopreservation of vascular tissues. Organogenesis. 2009;5(3):97-104.
Pukacki F, Jankowski T, Gabriel M, Oszkinis G, Krasinski Z, Zapalski S. The mechanical properties of fresh and cryopreserved arterial homografts. European Journal of Vascular and Endovascular Surgery. 2000;20:21-24.
Koskas F, Goeau-Brissonniere O, Nicolas MH, Bacourt F, Kieffer E. Arteries from human beings are less infectible by Staphylococcus aureus than polytetrafluoroethylene in an aortic dog model. J Vasc Surg. 1996;23(3): 472-476.
Antonopoulos N, Papakonstantinou A, Hardy D, Lyden S. Editor’s Choice — Cryopreserved Allografts for Arterial Reconstruction after Aorto-Iliac Infection: A Systematic Review and Meta-Analysis. J Vasc Surg. 2019;58(1):120-128.
Harlander-Locke MP, Harmon LK, Lawrence PF, Oderich GS, McCready RA, Morasch MD, Feezor RJ, Vascular Low-Frequency Disease Consortium; Zhou W, Bismuth J, Pevec WC, Correa MP, Jim J, Ladowski JS, Kougias P, Bove PG, Wittgen CM, White JV, Vascular Low-Frequency Disease Consortium. The use of cryopreserved aortoiliac allograft for aortic reconstruction in the United States. J Vasc Surg. 2014;59:669-674.
Vogt PR, Brunner-La Rocca HP, Carrel T, von Segesser LK, Ruef C, Debatin J, Seifert B, Kiowski W, Turina MI. Cryopreserved arterial allografts in the treatment of major vascular infection: a comparison with conventional surgical techniques. J Thorac Cardiovasc Surg. 1998;116:965-972.
Guevara-Noriega K, Lucar-Lopez G, Pomar J, Cryopreserved Allografts for Treatment of Chronic Limb-Threatening Ischemia in Patients Without Autologous Saphenous Veins. Ann Vasc Surg. 2019;60:379-387.
Dorigo W, Pulli R, Castelli P, Dorrucci V, Ferilli F, De Blasis G, Monaca V, Vecchiati E, Pratesi C, Propaten Italian Registry Group. A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical limb ischemia in diabetics. J Vasc Surg. 2011;54:1332-1338.
Masmejan S, Deslarzes-Dubuis C, Petitprez S, Longchamp A, Haller C, Saucy F, Corpataux J, Déglise S. Ten Year Experience of Using Cryopreserved Arterial Allografts for Distal Bypass in Critical Limb Ischaemia. Eur J Vasc Endovasc Surg. 2019;57(6):823-831.
Albertini JN, Barral X, Branchereau A, Favre JP, Guidicelli H, Magne JL, Magnan PE. Long-term results of arterial allograft below-knee bypass grafts for limb salvage: a retrospective multicenter study. J Vasc Surg. 2000;31: 426-435.
Получена 15.06.2020

Close metadata